{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:22:12Z","timestamp":1760242932893,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvoice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Voice"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jvoice.2021.01.007","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T09:01:15Z","timestamp":1611133275000},"page":"419-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Role of Famotidine and Other Acid Reflux Medications for SARS-CoV-2: A Pilot Study"],"prefix":"10.1016","volume":"37","author":[{"given":"Bailey","family":"Balouch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swetha","family":"Vontela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Yeakel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghiath","family":"Alnouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert T.","family":"Sataloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2020","series-title":"Coronavirus Disease (COVID-19). World Health Organization Web site","key":"10.1016\/j.jvoice.2021.01.007_bib0001"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0002","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1053\/j.gastro.2020.05.053","article-title":"Famotidine use is associated with improved clinical outcomes in hospitalized COVID-19 patients: a propensity score matched retrospective cohort study","volume":"159","author":"Freedberg","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0003","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.14309\/ajg.0000000000000832","article-title":"Impact of famotidine use on clinical outcomes of hospitalized patients with COVID-19","volume":"115","author":"Mather","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0004","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1136\/gutjnl-2020-321852","article-title":"Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series","volume":"69","author":"Janowitz","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0005","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/gutjnl-2020-322248","article-title":"Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching","volume":"70","author":"Lee","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0006","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/joim.13121","article-title":"Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor?","volume":"289","author":"Luxenburger","year":"2020","journal-title":"J Intern Med"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0007","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235460","article-title":"COVID-19 symptoms predictive of healthcare workers' SARS-CoV-2 PCR results","volume":"15","author":"Lan","year":"2020","journal-title":"PLoS One"},{"issue":"2 Suppl","key":"10.1016\/j.jvoice.2021.01.007_bib0010","doi-asserted-by":"crossref","first-page":"488S","DOI":"10.1093\/ajcn\/55.2.488s","article-title":"Pathophysiology of obesity","volume":"55","author":"Bray","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0011","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/coa.13269","article-title":"Alkaline, protein, low-fat and low-acid diet in laryngopharyngeal reflux disease: our experience on 65 patients","volume":"44","author":"Lechien","year":"2019","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0012","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5009\/gnl16615","article-title":"Current trends in the management of gastroesophageal reflux disease","volume":"12","author":"Sandhu","year":"2018","journal-title":"Gut Liver"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0013","series-title":"Obesity and the Voice","first-page":"183","article-title":"Reflux and other gastroenterologic conditions that may affect the voice","author":"Sataloff","year":"2020"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0014","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom10060954","article-title":"Class A g protein-coupled receptor antagonist famotidine as a therapeutic alternative against SARS-CoV2: an in silico analysis","volume":"10","author":"Ortega","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0016","first-page":"1","article-title":"Binding insight of clinically oriented drug famotidine with the identified potential target of SARS-CoV-2","author":"Sen Gupta","year":"2020","journal-title":"J Biomol Struct Dyn"},{"year":"2020","series-title":"SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles","author":"Bojkova","key":"10.1016\/j.jvoice.2021.01.007_bib0017"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0018","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.15585\/mmwr.mm6939e1","article-title":"Changing age distribution of the COVID-19 pandemic \u2014 United States","volume":"69","author":"Boehmer","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamainternmed.2020.3596","article-title":"Factors associated with death in critically ill patients with coronavirus disease 2019 in the US","volume":"180","author":"Gupta","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0020","doi-asserted-by":"crossref","first-page":"e13128","DOI":"10.1111\/obr.13128","article-title":"Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships","volume":"21","author":"Popkin","year":"2020","journal-title":"Obes Rev"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0021","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/oby.23029","article-title":"Independent role of morbid obesity as a risk factor for COVID-19 hospitalization: a Spanish population-based cohort study","volume":"29","author":"Fresan","year":"2020","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0022","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1258\/ebm.2010.010227","article-title":"The burden of obesity on infectious disease","volume":"235","author":"Karlsson","year":"2010","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0023","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1111\/j.1572-0241.2008.01946.x","article-title":"The association between gastroesophageal reflux disease and obesity","volume":"103","author":"Friedenberg","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0024","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.anorl.2020.04.014","article-title":"Consensus statement. Corticosteroid therapy in ENT in the context of the COVID-19 pandemic","volume":"137","author":"Herman","year":"2020","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"10.1016\/j.jvoice.2021.01.007_bib0025","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamaoto.2020.1622","article-title":"Benefits and safety of nasal saline irrigations in a pandemic-washing COVID-19 away","volume":"146","author":"Farrell","year":"2020","journal-title":"JAMA Otolaryngol Head Neck Surg"}],"container-title":["Journal of Voice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199721000321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199721000321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:42:11Z","timestamp":1760211731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892199721000321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0892199721000321"],"URL":"https:\/\/doi.org\/10.1016\/j.jvoice.2021.01.007","relation":{},"ISSN":["0892-1997"],"issn-type":[{"type":"print","value":"0892-1997"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Famotidine and Other Acid Reflux Medications for SARS-CoV-2: A Pilot Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Voice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvoice.2021.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Voice Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}